成人免费xx,国产又黄又湿又刺激不卡网站,成人性视频app菠萝网站,色天天天天

上海一飛生物科技有限公司 公司信息

公司名稱(chēng): 上海一飛生物科技有限公司
電話(huà): 021-65675885
電子郵件:customer_service@efebio.com
國(guó)籍:中國(guó)
網(wǎng)址: http://www.efebio.com
產(chǎn)品總數(shù):11974
89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120

公司提供產(chǎn)品列表

Basroparib 化合物 BASROPARIB 1858179-75-5
SU 5616 5-氯-3-(噻吩-2-基亞甲基)吲哚啉-2-酮 186611-58-5
Resomelagon 化合物 RESOMELAGON 1809420-71-0
Berberine ursodeoxycholate WX-0593 1868138-66-2
Propionic-2,2-d2 acid 甲基乙酸-2,2-D2 19136-91-5
Diprogulic acid 調(diào)呋酸（一水） 18467-77-1
PF-06761281 PF-06761281 1854061-19-0
BRD2492 化合物 T26897 1821669-43-5
Cofetuzumab Cofetuzumab 1869928-62-0
Cis-22a CIS-22A 1819366-84-1
SMO-IN-2 化合物 SMO-IN-2 1822355-27-0
(R)-CJ 11974 化合物(R)-CJ 11974 187281-35-2
JTV-519 fumarate JTV519) 1883549-36-7
Cbz-B3A Cbz-B3A 1884710-81-9
Mosunetuzumab 莫妥珠單抗 1905409-39-3
Fmoc-aminooxy-PEG2-NH2 FMOC-AMINOOXY-PEG2-NH2 190249-87-7
Acloproxalap 化合物 ACLOPROXALAP 1824609-67-7
NTRC 0066-0 NTRC 00660 1817791-73-3
Linvencorvir 化合物 LINVENCORVIR 1808248-05-6
Iruplinalkib 伊魯阿克 1854943-32-0
NBI-27914 5-CHLORO-N-(CYCLOPROPYLMETHYL)-2-METHYL-N-PROPYL-N'-(2,4,6-TRICHLOROPHENYL)-4,6-PYRIMIDINEDIAMINE HYDROCHLORIDE 184241-44-9
3-phenylpropanoic-2,2-d2 acid HYDROCINNAMIC-2,2-D2 ACID 19136-97-1
1,4-Dideoxy-1,4-epithio-D-ribitol 1,4-二脫氧-1,4-環(huán)硫-D-核糖醇 190315-43-6
NS1-IN-1 SID 124981180 181373-35-3
Aplindore Fumarate Aplindore fumarate 189681-71-8
CXCR2-IN-2 CXCR2-IN-2 1838123-21-9
Gedivumab Gedivumab 1807954-17-1
Lacnotuzumab Lacnotuzumab 1831128-32-5
Tislelizumab 替雷利珠單抗 1858168-59-8
Omburtamab 奧博妥單抗 1895083-75-6
Gatralimab GATRALIMAB (格曲利單抗 ) 1826020-80-7
Cofrogliptin 化合物 COFROGLIPTIN 1844874-26-5
cPrPMEDAP 182798-83-0
Ezurpimtrostat hydrochloride 化合物 EZURPIMTROSTAT HYDROCHLORIDE 1914148-73-4
Anticonvulsant agent 10 HCl 化合物T39252L 1818253-48-3
Gantofiban GANTOFIBAN 183547-57-1
Ursolic aldehyde 熊果醛 19132-81-1
PF-06649298 PF-06649298 1854061-16-7
PF-06737007 PF-06737007 1863905-38-7
Talacotuzumab Talacotuzumab 1826831-79-1
Naxitamab NAXITAMAB (那昔妥單抗 ) 1879925-92-4
Rezivertinib REZIVERTINIB 1835667-12-3
hCYP3A4 Fluorogenic substrate 1 100MG 186299-00-3
Cibisatamab 賽必妥單抗 1855925-27-7
EPZ032597 化合物EPZ032597 1887193-58-9
Clenoliximab clenoliximab 182912-58-9
FM04 化合物FM04 1807320-40-6
Iladatuzumab 1906205-76-2
Enapotamab ENAPOTAMAB單抗 1912423-61-0
Smurf-1 modulator CMP Example 20 LTP001 1825371-51-4
CXCR2 antagonist 8 化合物 CXCR2 ANTAGONIST 8 182498-30-2
Br-PEG4-THP 溴-四聚乙二醇-四氫吡喃醚 1803547-60-5
Tisolagiline (S)-2-(((4'-(TRIFLUOROMETHYL)-[1,1'-BIPHENYL]-4-YL)METHYL)AMINO)PROPANAMIDE 1894207-44-3
SDH-IN-2 SDH抑制劑2 1823354-06-8
FFN 206 dihydrochloride FFN 206二鹽酸鹽 1883548-88-6
GlyT1 Inhibitor 1 GlyT1 Inhibitor 1 1820934-93-7
Azintuxizumab Azintuxizumab 1826819-57-1
Gilvetmab Gilvetmab 1808081-43-7
N-Nitroso-N-methylaniline-d5 化合物 N-NITROSO-N-METHYLANILINE-D5 1821341-18-7
NS-2710 化合物 T28197 184220-36-8
Zamaporvint RXC004 1900754-56-4
HDAC8-IN-20a HDAC8-IN-20a 1884231-52-0
Tibulizumab Tibulizumab 1849636-24-3
Tinlarebant 1-[3-[[4-[3,4-二氟-2-(三氟甲基)苯基]-1-哌啶基]羰基]-1,4,5,7-四氫-6H-吡唑并[3,4-C]吡啶-6-基]乙酮 1821327-95-0
TriGalNAc CBz 5-[(3,4,6-三-O-苯甲酰基-2-乙酰氨基-2-脫氧-Β-D-吡喃半乳糖基)氧基]-戊酸 186613-57-0
Edralbrutinib 化合物 EDRALBRUTINIB 1858206-58-2
TAK-418 化合物 TAK-418 1818252-53-7
EPZ033294 化合物EPZ033294 1887195-17-6
Trifluoromethyl-tubercidin 三氟甲基結(jié)核菌素 1854086-05-7
(Iso)-Rilmakalim 化合物T26086L 184653-89-2
Tofimilast 化合物 T28991 185954-27-2
Dersalazine DERSALAZINE 無(wú)結(jié)構(gòu)圖 188913-58-8
Idelalisib D5 Idelalisib D5 1830330-31-8
Mirikizumab Mirikizumab 1884201-71-1
OPC-167832 OPC-167832 1883747-71-4
PB1 PB1 188714-28-5
TRV-120027 acetate (1234510-46-3 free base) TRV120027 acetate (1234510463 free base),TRV 120027 acetate (1234510 46 3 free base) 1824712-70-0
ZY-19489 化合物T67694 1821293-40-6
Zavondemstat QC8222|||TACH 101|||TACH101 1851412-93-5
STC314 化合物 STC314 186295-19-2
EGFR-IN-87 化合物 EGFR-IN-87 1835666-87-9
L-161240 (4R)-2-(3,4-二甲氧基-5-丙基苯基)-4,5-二氫-N-羥基-4-惡唑甲酰胺 183298-68-2
MMPP (E)-2-甲氧基-4-(3-(4-甲氧基苯基)丙烯基苯酚 1895957-18-2
Fentiazac 氯苯噻乙酸 18046-21-4
YNT-185 dihydrochloride YNT-185 DIHYDROCHLORIDE HYDRATE 1804978-82-2
Setrusumab 1847394-95-9
Loncastuximab Loncastuximab 1875032-68-0
AY 77 AY77 1835734-92-3
(3S,4S)-PF-06459988 (3S,4S)-PF-06459988 1858291-14-1
Lorundrostat 化合物 LORUNDROSTAT 1820940-17-7
CJJ300 化合物 CJJ300 1807631-83-9
EM127 化合物 EM127 1886879-71-5
Tyrosinase-IN-12 TYROSINASE抑制劑12 1860779-42-5
HS94 HS94 1892594-93-2
IACS-010759 hydrochloride 1807523-99-4 1807523-99-4
TBDMS-PEG4-Acid TBDMS-PEG4-Acid 1807540-77-7
Duvortuxizumab Duvortuxizumab 1831098-91-9
Lesofavumab Lesofavumab 1807960-57-1
YNT-185 YNT185 1804978-81-1
MLT-985 MLT-985 1832576-25-6
89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120
Copyright 2007? ChemicalBook. All rights reserved.